XNCR$29.822.09%0.61
After Hours: 30.10+0.28 +0.94%
Xencor Inc (XNCR)
Date: 2026-10-30 16:00O: 29.09H: 30.05L: 28.61C: 29.82Vol: 1.286M
Xencor Inc stock is traded at $29.82, with a volume of 1,285,581. It is up +2.09% in the last 24 hours and up +19.52% over the past month. Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Previous Close:
$29.21
Open:
$29.09
24h Volume:
1,285,581
Relative Volume:
0.60
Market Cap:
$2.22B
Revenue:
$97.36M
Net Income/Loss:
-$172.42M
P/E Ratio:
-
EPS:
-$2.30
Net Cash Flow:
-$188.84M
1W Performance:
+18.43%
1M Performance:
+19.52%
6M Performance:
+149.96%
1Y Performance:
+111.04%
1-Day Range:
$28.61$30.05
1-Week Range:
$27.76$33.60
52-Week Range:
$10.38$33.60
Xencor Inc Stock (XNCR) Company Profile
Name
Xencor IncSector
HealthcareIndustry
BiotechnologyPhone
626-305-5900Address
465 N. HALSTEAD ST., PASADENA, CA, USACompare XNCR vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XNCR Xencor Inc | $29.82 | $2.22B | $97.36M | -$172.42M | -$188.84M | -$2.30 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
Xencor Inc Stock (XNCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Xencor Inc Stock (XNCR) Insider Trading
- Feigal EllenJun 18 '26Director
- Transaction
- Proposed Sale
- Cost
- $13.06
- #Shares
- 6,843
- Value ($)
- 89,370
- #Shares Total
- 0
- GORMAN KEVIN CHARLESJun 15 '26Director
- Transaction
- Proposed Sale
- Cost
- $12.31
- #Shares
- 7,527
- Value ($)
- 92,657
- #Shares Total
- 0
- GUSTAFSON KURT AJun 15 '26Director
- Transaction
- Proposed Sale
- Cost
- $12.31
- #Shares
- 5,474
- Value ($)
- 67,385
- #Shares Total
- 0
- RANIERI RICHARD JJun 15 '26Director
- Transaction
- Proposed Sale
- Cost
- $12.31
- #Shares
- 5,474
- Value ($)
- 67,385
- #Shares Total
- 0
- Montgomery Alan BruceJun 15 '26Director
- Transaction
- Proposed Sale
- Cost
- $12.31
- #Shares
- 5,064
- Value ($)
- 62,338
- #Shares Total
- 0
- Montgomery Alan BruceJun 15 '26Director
- Transaction
- Sale
- Cost
- $12.31
- #Shares
- 5,064
- Value ($)
- 62,338
- #Shares Total
- 15,547
- RANIERI RICHARD JJun 15 '26Director
- Transaction
- Sale
- Cost
- $12.31
- #Shares
- 5,474
- Value ($)
- 67,385
- #Shares Total
- 13,709
- GORMAN KEVIN CHARLESJun 15 '26Director
- Transaction
- Sale
- Cost
- $12.31
- #Shares
- 7,527
- Value ($)
- 92,657
- #Shares Total
- 11,378
- GUSTAFSON KURT AJun 15 '26Director
- Transaction
- Sale
- Cost
- $12.31
- #Shares
- 5,474
- Value ($)
- 67,385
- #Shares Total
- 14,709
- Cornelissen Bart JanApr 10 '26SR. VICE PRESIDENT & CFO
- Transaction
- Sale
- Cost
- $12.29
- #Shares
- 3,499
- Value ($)
- 42,990
- #Shares Total
- 75,898
